FR2741071B1 - Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique - Google Patents

Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique

Info

Publication number
FR2741071B1
FR2741071B1 FR9513256A FR9513256A FR2741071B1 FR 2741071 B1 FR2741071 B1 FR 2741071B1 FR 9513256 A FR9513256 A FR 9513256A FR 9513256 A FR9513256 A FR 9513256A FR 2741071 B1 FR2741071 B1 FR 2741071B1
Authority
FR
France
Prior art keywords
oxazolidin
benzofuran
derivatives
preparation
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9513256A
Other languages
English (en)
Other versions
FR2741071A1 (fr
Inventor
Samir Jegham
Frederic Puech
Philippe Burnier
Danielle Berthon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9513256A priority Critical patent/FR2741071B1/fr
Priority to JP9517918A priority patent/JP2000500126A/ja
Priority to PCT/FR1996/001731 priority patent/WO1997017346A1/fr
Priority to EP96937391A priority patent/EP0859775A1/fr
Priority to US09/066,365 priority patent/US6143772A/en
Publication of FR2741071A1 publication Critical patent/FR2741071A1/fr
Application granted granted Critical
Publication of FR2741071B1 publication Critical patent/FR2741071B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
FR9513256A 1995-11-09 1995-11-09 Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique Expired - Fee Related FR2741071B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9513256A FR2741071B1 (fr) 1995-11-09 1995-11-09 Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
JP9517918A JP2000500126A (ja) 1995-11-09 1996-11-05 ３−（ベンゾフラン−５−イル）オキサゾリジン−２−オンから誘導される化合物、その製造方法およびその治療上の用途
PCT/FR1996/001731 WO1997017346A1 (fr) 1995-11-09 1996-11-05 Composes derives de 3-(benzofuran-5-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
EP96937391A EP0859775A1 (fr) 1995-11-09 1996-11-05 Composes derives de 3-(benzofuran-5-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
US09/066,365 US6143772A (en) 1995-11-09 1996-11-05 Compounds derived from 3-(benzofuran-5-yl)oxazolidin-2-one, preparation method therefor and therapeutical use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513256A FR2741071B1 (fr) 1995-11-09 1995-11-09 Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2741071A1 FR2741071A1 (fr) 1997-05-16
FR2741071B1 true FR2741071B1 (fr) 1997-12-12

Family

ID=9484383

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9513256A Expired - Fee Related FR2741071B1 (fr) 1995-11-09 1995-11-09 Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique

Country Status (5)

Country Link
US (1) US6143772A (fr)
EP (1) EP0859775A1 (fr)
JP (1) JP2000500126A (fr)
FR (1) FR2741071B1 (fr)
WO (1) WO1997017346A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3865450B2 (ja) * 1997-02-14 2007-01-10 田辺製薬株式会社 パーキンソニズム治療剤
DE19730847A1 (de) * 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
CA2319318A1 (fr) * 1998-01-27 1999-07-29 Thomas N. Thomas Methodes de traitement utilisant des inhibiteurs mao-a et mao-b tel que le l-deprenyle
IL146389A0 (en) 2001-11-08 2002-07-25 Isp Finetech Ltd Process for the preparation of dronedarone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1180089A (en) * 1967-10-20 1970-02-04 Delalande Sa Acetylenic Derivatives of 2-Oxazolidinones and processes of preparation
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
EP0006524A1 (fr) * 1978-06-22 1980-01-09 Ciba-Geigy Ag Dérivés de tétrahydropyridine et de tétrahydropipéridine, leurs sels d'addition acides, procédés pour leur préparation et compositions pharmaceutiques les contenant
CA1171865A (fr) * 1980-06-04 1984-07-31 Alain Lacour Derives de n-aryl-azolone, methode de preparation et utilisation a des fins therapeutiques
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone

Also Published As

Publication number Publication date
FR2741071A1 (fr) 1997-05-16
JP2000500126A (ja) 2000-01-11
EP0859775A1 (fr) 1998-08-26
WO1997017346A1 (fr) 1997-05-15
US6143772A (en) 2000-11-07

Similar Documents

Publication Publication Date Title
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2595695B1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2741071B1 (fr) Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2672601B1 (fr) Derives de benzo-1,5-thiazepine, leur preparation et leur application en therapeutique.
FR2638747B1 (fr) Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2668152B1 (fr) Derives n,o spirocycliques de cyclotriphosphazenes, leur preparation et leur application en therapeutique.
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2750427B1 (fr) Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
FR2688504B1 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2727413B1 (fr) Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique
FR2734820B1 (fr) Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2738567B1 (fr) Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
FR2772760B1 (fr) Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4- propanamide, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2754261B1 (fr) Derives de quinuclidine, leur preparation et leur application en therapeutique
FR2672891B1 (fr) Derives de 3-pyrazolones, leur preparation et leur application en therapeutique.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse
ST Notification of lapse